Lataa...
Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study
OBJECTIVES: To analyze the efficacy and safety of dolutegravir/rilpivirine (DTG/RPV) in HIV-infected patients who switched from any other antiretroviral therapy (ART). METHODS: Open-label, multicenter study including patients who switched to DTG/RPV between February 2015 and February 2016. Efficacy...
Tallennettuna:
| Julkaisussa: | J Int Assoc Provid AIDS Care |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6748491/ https://ncbi.nlm.nih.gov/pubmed/29529910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2325958218760847 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|